Description
Indication & Scope
AoFuMin® is a prescription recombinant human albumin indicated for the treatment of hypoalbuminemia in adult patients with liver cirrhosis and serum albumin levels of ≤30 g/L.
- Mechanism: Recombinant human albumin is produced using a rice endosperm expression platform and has the same amino acid sequence and biological functions as plasma-derived human albumin. It increases plasma colloid osmotic pressure, expands circulating plasma volume, and corrects hypoalbuminemia.
- Drug class: Recombinant human albumin.
- Clinical use: Treatment of hypoalbuminemia in adults with liver cirrhosis.
| Generic Name | Recombinant Human Albumin Injection |
| Brand Name | AoFuMin® |
| Ingredient | Recombinant Human Albumin |
| Dosage Form | Injection |
| Package | 10 g/50 mL per vial |
| Conditions Treated | Hypoalbuminemia in adults with liver cirrhosis (serum albumin ≤30 g/L) |
| Taboos | Hypersensitivity to recombinant human albumin, human albumin, or any component of the product |
| Place of origin | China |
| Prescription type | Prescription Drug (Rx) |
| Storage Conditions | Store refrigerated at 2–8°C and protect from light. Use within 4 hours after opening. Do not freeze. |
| Manufacturer | Wuhan Healthgen Biotechnology Corp. |
| Registration Authority | National Medical Products Administration (NMPA), China |
| Approval number | S20250039 |
| Date of Revision | 2025 |
| Shelf Life | 24 months |
How to use ?
Recommended Dose: Administer by intravenous infusion. The dosage and infusion rate should be individualized according to the patient’s clinical condition, circulating blood volume, and degree of albumin deficiency.
Time: Initiate the infusion slowly during the first 15 minutes. In patients with normal blood volume, the infusion rate should generally not exceed 2 mL/min.
Instructions for use: For intravenous use only. Do not administer intramuscularly or subcutaneously. Once opened, the solution should be infused within 4 hours, and any unused portion should be discarded. Monitor serum albumin levels, fluid status, and liver and renal function during treatment.
Interaction: No clinically significant drug interactions have been identified. Do not mix this product with other medicinal products in the same infusion container.
Side effects: Common adverse reactions include headache, flushing, nausea, and infusion-site reactions. Rare hypersensitivity reactions may occur. Excessive infusion may lead to hypervolemia and circulatory overload, particularly in patients with cardiac impairment.
Important Notice
This product should be administered only by qualified healthcare professionals in accordance with the approved prescribing information and local clinical guidelines. Dosage and administration may vary depending on patient condition, indicatiaon, and regional regulatory requirements.
Packaging & Shipping
Packaging
Original manufacturer’s packaging with secure export carton. Customized export packaging is available upon request.
Shipping Methods
Express Courier (EMS, DHL, FedEx, UPS), Air Freight, and Sea Freight. Cold-chain transportation is available for products requiring temperature-controlled logistics.
Export Support
Certificate of Analysis
GMP Certificate
Commercial Invoice
Packing List & CPP
Cold Chain Logistics
Customs Documentation
Scientific and regulatory sources
FAQ
What is AoFuMin® used for?
AoFuMin® is indicated for the treatment of hypoalbuminemia in adults with liver cirrhosis whose serum albumin level is ≤30 g/L.
How is AoFuMin® different from plasma-derived human albumin?
AoFuMin® is produced using a rice-derived recombinant expression platform and does not rely on human plasma, eliminating the risk of blood-borne pathogen transmission.
How is AoFuMin® administered?
AoFuMin® is administered by intravenous infusion under medical supervision, with dosage determined according to the patient’s clinical condition.
What are the common side effects of AoFuMin®?
The most common adverse reactions include headache, flushing, nausea, and infusion-site reactions. Serious adverse reactions are uncommon.
AoFuMin® | Recombinant Human Albumin | Hypoalbuminemia in Liver Cirrhosis | DengYueRX (复制)
INN: Recombinant Human Albumin
Indications: Hypoalbuminemia in adults with liver cirrhosis
Dosage Form: Injection
Strength: 10 g/50 mL (20%)
Price range: $9.00 through $11.00
Low MOQ
WHO-GMP
Worldwide Delivery
Compliance and Regulatory Documents
Related Products
